These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 349657)

  • 61. Von Willebrand's disease: studies of platelet functions, factor VIII procoagulant activity (F VIII C) and factor VIII-related antigen (F VIII RAg) in three families.
    Mahasandana C; Suvatte V; Püng-amritt P; Tuchinda S
    Southeast Asian J Trop Med Public Health; 1979 Jun; 10(2):243-7. PubMed ID: 316576
    [No Abstract]   [Full Text] [Related]  

  • 62. The defect in hemophilic and von Willebrand's disease plasmas studied by a recombination technique.
    Cooper HA; Wagner RH
    J Clin Invest; 1974 Nov; 54(5):1093-9. PubMed ID: 4213756
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Nature of haemophilia and von Willebrand's disease.
    Ekert H; Muntz RH
    Aust N Z J Med; 1974 Feb; 4(1):66-70. PubMed ID: 4602351
    [No Abstract]   [Full Text] [Related]  

  • 64. Combined haemophilia A and type I von Willebrand's disease: a family study including an evaluation of the effects of DDAVP infusion.
    Casonato A; Pontara E; Boscaro M; Dannhauser D; Sartori MT; Girolami A
    Haematologia (Budap); 1993; 25(1):57-67. PubMed ID: 8339998
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Two genetic variants of von Willebrand's disease.
    Holmberg L; Nilsson IM
    N Engl J Med; 1973 Mar; 288(12):595-8. PubMed ID: 4539979
    [No Abstract]   [Full Text] [Related]  

  • 66. Clinical observations and their relationship to laboratory findings in the haemophilias.
    Rainsford SG; Hall A
    Thromb Diath Haemorrh; 1975 Dec; 34(3):734-9. PubMed ID: 1082180
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinical application of a chromogenic substrate method for determination of factor VIII activity.
    Rosén S; Andersson M; Blombäck M; Hägglund U; Larrieu MJ; Wolf M; Boyer C; Rothschild C; Nilsson IM; Sjörin E
    Thromb Haemost; 1985 Dec; 54(4):818-23. PubMed ID: 3937277
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Properties of post-infusion factor VIII in von Willebrand's disease.
    Muntz RH; Ekert H; Helliger H
    Thromb Res; 1974 Aug; 5(2):111-23. PubMed ID: 4547286
    [No Abstract]   [Full Text] [Related]  

  • 69. Different properties of Factor VIII in von Willebrand's disease with Respectto Recovery in Cryoprecipitate.
    Stibbe J; Van Der Plas PM; Hemker HC
    Haemostasis; 1974; 3(3):142-8. PubMed ID: 4549307
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Classic hemophilia A in a female.
    Joist JH; Bouhasin JD; Roodman S
    Acta Haematol; 1977; 58(2):94-102. PubMed ID: 409025
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Molecular defects in haemophilia A and von Willebrand's disease.
    Gralnick HR; Coller BS
    Lancet; 1976 Apr; 1(7964):837-8. PubMed ID: 56653
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The spectrum of von Willebrand's disease revisited.
    Bowie EJ; Fass DN; Olson JD; Owen CA
    Mayo Clin Proc; 1976 Jan; 51(1):35-41. PubMed ID: 765637
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Gel filtration patterns of factor VIII coagulant antigen and factor VIII related antigen in normal and von Willebrand's disease.
    Chediak J; Peake I; Bloom A
    Thromb Haemost; 1983 Aug; 50(2):509-12. PubMed ID: 6415844
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Von Willebrand's disease in two families. Case reports with a contribution to the management of chronic intestinal hemorrhages.
    Salomon H; Tatarski I
    Isr J Med Sci; 1965 Jul; 1(4):866-9. PubMed ID: 5295184
    [No Abstract]   [Full Text] [Related]  

  • 75. Immunological characterization of purified anti-haemophilic factor A (factor VIII) which corrects abnormal platelet retention in Von Willebrand's disease.
    Bouma BN; Wiegerinck Y; Sixma JJ; Van Mourik JA; Mochtar IA
    Nat New Biol; 1972 Mar; 236(65):104-6. PubMed ID: 4112547
    [No Abstract]   [Full Text] [Related]  

  • 76. A variant of von Willebrand's disease with abnormal expression of factor VIII procoagulant activity.
    Montgomery RR; Hathaway WE; Johnson J; Jacobson L; Muntean W
    Blood; 1982 Jul; 60(1):201-7. PubMed ID: 6805535
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Low-molecular-weight factor VIII.
    Bloom AL; Giddings JC; Peake IR
    Lancet; 1973 May; 1(7810):1000. PubMed ID: 4121554
    [No Abstract]   [Full Text] [Related]  

  • 78. Factor VIII physiology and pathology in man.
    Koutts J; Howard MA; Firkin BG
    Prog Hematol; 1979; 11():115-45. PubMed ID: 392590
    [No Abstract]   [Full Text] [Related]  

  • 79. Detection of heterozygotes for recessive von Willebrand's disease by the assay of antihemophilic-factor-like antigen.
    Veltkamp JJ; van Tilburg NH
    N Engl J Med; 1973 Oct; 289(17):882-5. PubMed ID: 4542316
    [No Abstract]   [Full Text] [Related]  

  • 80. Correction of the platelet abnormality in von Willebrand's disease by cryoprecipitate.
    Weiss HJ; Rogers J
    Am J Med; 1972 Dec; 53(6):734-8. PubMed ID: 4539018
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.